EVMN
NYSE · Biotechnology
Evommune Inc
$9.65
+0.28 (+2.99%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+685.5% upside
Low Target
$52.19
Average Target
$75.80
High Target
$91.23
Current Price
$9.65
Current
$9.65
$9.65
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Scenario Analysis
Bear Case
$52.19
440.8%
Low target
Base Case
$75.80
+685.5%
Avg target
Bull Case
$91.23
+845.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$33.20
-70.9% from high
52-Week Low
$9.30
+3.8% from low
Target vs 52W High
$75.80
+128.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |